Aesthetic Medical International Holdings Group Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Aesthetic Medical International Holdings Group yıllık ortalama 2.8% oranında kazançlarını artırırken, Healthcare sektöründe kazançlar growing at 7.2% annual. Gelirler azalıyor .

Anahtar bilgiler

2.8%

Kazanç büyüme oranı

11.3%

EPS büyüme oranı

Healthcare Sektör Büyümesi	15.7%
Gelir büyüme oranı	-5.8%
Özkaynak getirisi	-496.6%
Net Marj	-6.7%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Aesthetic Medical International Holdings Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

DB:3FMA Gelir, gider ve kazançlar (CNY Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	727	-48	388
31 Mar 24	715	-48	392
31 Dec 23	683	-37	371
30 Sep 23	665	-44	358
30 Jun 23	651	-82	359
31 Mar 23	658	-73	360
31 Dec 22	670	-76	377
30 Sep 22	549	-363	466
30 Jun 22	678	-198	496
31 Mar 22	671	-503	560
31 Dec 21	646	-587	612
30 Sep 21	965	-358	692
30 Jun 21	1,078	-360	756
31 Mar 21	946	-243	748
31 Dec 20	902	-235	741
30 Sep 20	777	-216	700
30 Jun 20	734	-83	656
31 Mar 20	779	35	634
31 Dec 19	869	136	609
30 Sep 19	844	-89	522
30 Jun 19	798	-192	470
31 Mar 19	764	-242	448
31 Dec 18	761	-255	449
31 Dec 17	697	-77	393
31 Dec 16	585	50	314

Kaliteli Kazançlar: 3FMA şu anda kârlı değil.

Büyüyen Kar Marjı: 3FMA şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 3FMA kârlı değildir, ancak son 5 yılda zararlarını yılda 2.8% oranında azaltmıştır.

Büyüme Hızlandırma: 3FMA 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: 3FMA kârlı olmadığından, geçmiş yıl kazanç büyümesinin Healthcare sektörüyle ( 40.5% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: 3FMA hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -496.55% ) sahiptir.

Aesthetic Medical International Holdings Group Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

First half 2024 earnings released: CN¥0.45 loss per share (vs CN¥0.24 loss in 1H 2023)

Full year 2023 earnings released: CN¥0.84 loss per share (vs CN¥2.79 loss in FY 2022)

Aesthetic Medical International Holdings Group Limited to Report Fiscal Year 2023 Final Results on Apr 25, 2024

Second quarter 2023 earnings released: CN¥0.24 loss per share (vs CN¥0.062 loss in 2Q 2022)

Aesthetic Medical International Holdings Group Limited to Report Q1, 2023 Results on May 17, 2023

Full year 2022 earnings released: CN¥2.79 loss per share (vs CN¥26.68 loss in FY 2021)

Recent updates

First half 2024 earnings released: CN¥0.45 loss per share (vs CN¥0.24 loss in 1H 2023)

New major risk - Market cap size

Aesthetic Medical International Holdings Group Limited(OTCPK:PAIY.Y) dropped from NASDAQ Composite Index

Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel

Aesthetic Medical International Holdings Group Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing

Full year 2023 earnings released: CN¥0.84 loss per share (vs CN¥2.79 loss in FY 2022)

Aesthetic Medical International Holdings Group Limited to Report Fiscal Year 2023 Final Results on Apr 25, 2024

New minor risk - Financial data availability

Aesthetic Medical International Holdings Announces Receipt of Letter of Expected Delisting Determination from Nasdaq Staff and Intention to Request Hearing Before the Nasdaq Hearings Panel

Aesthetic Medical International Holdings Group Limited Announces Change of Director

Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Second quarter 2023 earnings released: CN¥0.24 loss per share (vs CN¥0.062 loss in 2Q 2022)

Aesthetic Medical International Holdings Group Limited Announces Board and Committee Changes

An unknown buyer entered into an agreement to acquire Shenzhen Miaoyan Medical Technology Investment Co., Ltd. from Aesthetic Medical International Holdings Group Limited (NasdaqCM:AIH) for CNY 1.9 million.

Aesthetic Medical International Holdings Group Limited to Report Q1, 2023 Results on May 17, 2023

Full year 2022 earnings released: CN¥2.79 loss per share (vs CN¥26.68 loss in FY 2021)

Aesthetic Medical International Holdings Group Limited announced that it has received CNY 170.000002 million in funding from Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)

Aesthetic Medical International Holdings Receives a Letter of Expected Delisting Determination from Nasdaq Staff and Requests a Hearing Before the Nasdaq Hearings Panel

Third quarter 2022 earnings released: CN¥1.12 loss per share (vs CN¥7.50 loss in 3Q 2021)

Aesthetic Medical International Holdings Group Limited to Report Q3, 2022 Results on Nov 29, 2022

Less than half of directors are independent

Second quarter 2022 earnings released: CN¥0.062 loss per share (vs CN¥1.65 loss in 2Q 2021)

Aesthetic Medical International Holdings Group Limited to Report First Half, 2022 Results on Aug 17, 2022

Aesthetic Medical International Holdings Group Limited, Annual General Meeting, Sep 08, 2022

Less than half of directors are independent

Aesthetic Medical International Holdings Group Limited announced that it expects to receive CNY 170.000002 million in funding from Hainan Oriental Jiechuang Investment Partnership

Aesthetic Medical International Holdings Group Limited announced that it has received CNY 99.999999 million in funding from Lafang China Co.,Ltd, Hawyu (HK) Limited

Aesthetic Medical International Receives Nasdaq Notice Regarding Non-Compliance with Minimum Stockholders’ Equity Requirement

Less than half of directors are independent

Aesthetic Medical International Announces Change of Board Members and Committee Composition

Less than half of directors are independent

Second quarter 2021 earnings released: CN¥1.65 loss per share (vs CN¥2.85 loss in 2Q 2020)

Less than half of directors are independent

First quarter 2021 earnings released: CN¥0.84 loss per share (vs CN¥3.66 loss in 1Q 2020)

Aesthetic Medical International Holdings Group Limited Provides Revenue Guidance for the Second Quarter of 2021

Aesthetic Medical International Holdings Group Limited announced that it expects to receive $15.099993 million in funding from Lafang China Co.,Ltd

Full year 2020 earnings released: EPS CN¥10.83 (vs CN¥8.87 in FY 2019)

Aesthetic Medical International Holdings Group Limited Reports Impairment of Non-Current Assets for the Fourth Quarter of 2020

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin